Experimental type 1 diabetes metabolically rejuvenates CD8+ T cells for improved control of tumor growth through an IGF1-IGF1R axis
Anirban Sarkar, Sukanya Dhar, Saurav Bera, Mohona Chakravarti, Ayushi Verma, Muqtada Ali Khan, Parash Prasad, Juhina Das, Pritha Roy Choudhury, Jasmine Sultana, Akata Saha, Avishek Bhuniya, Ipsita Guha, Shayani Dasgupta, Sib Sankar Roy, , Anamika Bose
This study shows that experimental type 1 diabetes enhances CD8+ T cell function via the IGF1-IGF1R axis, leading to better tumor control.
The Journal of Immunology · Oct 1, 2026Peer-reviewedCancer Biology